Ovoca Bio plc (ISE:OVXA)

Ireland flag Ireland · Delayed Price · Currency is EUR
0.0105
0.00 (0.00%)
Inactive · Last trade price on Jun 4, 2025
10.53%
Market Cap 856.42K
Revenue (ttm) n/a
Net Income (ttm) -3.57M
Shares Out 81.56M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open n/a
Previous Close 0.0105
Day's Range n/a
52-Week Range 0.0050 - 0.0300
Beta 0.69
RSI 23.17
Earnings Date Jun 25, 2025

About Ovoca Bio

Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for women health. It’s lead product is BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1985
Employees 5
Stock Exchange Euronext Dublin
Ticker Symbol OVXA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.